Minimal Impact of the <scp>COVID</scp> ‐19 Pandemic on Disease Activity and <scp>Health‐Related</scp> Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b <scp>Open‐Label</scp> Extension Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Minimal Impact of the COVID ‐19 Pandemic on Disease Activity and Health‐Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open‐Label Extension Study

Published:2022-07-14 Issue:9 Volume:4 Page:819-824
ISSN:2578-5745
Container-title:ACR Open Rheumatology
language:en
Short-container-title:ACR Open Rheumatology

Author:

Robinson Philip C.¹^ORCID,Machado Pedro M.²,Haroon Nigil³^ORCID,Gensler Lianne S.⁴^ORCID,Reveille John D.⁵^ORCID,Taieb Vanessa⁶,Vaux Thomas⁷,Fleurinck Carmen⁸,Oortgiesen Marga⁹,de Peyrecave Natasha⁸,Deodhar Atul¹⁰^ORCID

Affiliation:

1. University of Queensland School of Clinical Medicine Brisbane Queensland Australia

2. University College London London UK

3. Toronto Western Hospital, University of Toronto and Schroeder Arthritis Institute Toronto Ontario Canada

4. University California San Francisco

5. The University of Texas McGovern Medical School Houston

6. UCB Pharma Colombes France

7. UCB Pharma Slough UK

8. UCB Pharma Brussels Belgium

9. UCB Pharma Raleigh North Carolina

10. Oregon Health & Science University Portland

Funder

UCB Pharma

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11486

Reference16 articles.

1. Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine

2. Factors related to health-related quality of life in ankylosing spondylitis, overall and stratified by sex

3. Sleep disturbances are associated with increased pain, disease activity, depression, and anxiety in ankylosing spondylitis: a case-control study

4. Patient‐reported Disease Activity in an Axial Spondyloarthritis Cohort during the COVID‐19 Pandemic

5. Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3